Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Protarga enters CRADA with NCI for novel anticancer therapies

May 4, 2000

NeoPharm files IND for antibody-targeted toxin

May 3, 2000

Patent licensed to GenStar covers gene therapy for sensitizing tumors to radiation

May 3, 2000

Coulter and SB modify Bexxar collaboration; phase II combination trial commences

May 3, 2000

Paxene receives marketing approval in Canada for Kaposi's sarcoma

May 2, 2000

ImClone Systems receives notice of allowability for cancer immunotherapy

May 2, 2000

Aphton begins trial of anti-G17 immunogen in metastatic gastric cancer

May 2, 2000

Novel platinum antitumor agent compares favorably with cisplatin in preclinical studies

May 2, 2000

Selectin inhibitors under study by Otsuka

May 2, 2000

Treatment and diagnosis of tumors using urokinase inhibitors

May 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...